Ogkologos

4396 POSTS 0 COMMENTS

Efficacy and Safety of FOLFIRI With Durvalumab With or Without Tremelimumab...

Ogkologos - April 22, 2024

Scientists Link a Single Type of Bacteria to Colorectal Cancer

Ogkologos - April 19, 2024

FDA Approves Safety Labelling Changes Regarding DPD Deficiency for Fluorouracil Injection...

Ogkologos - April 19, 2024

Adjuvant Alectinib Significantly Improves Disease-Free Survival in Patients with Resected ALK-positive...

Ogkologos - April 18, 2024

Adding Gemcitabine to Cisplatin Once per Week Concurrently with IMRT Significantly...

Ogkologos - April 17, 2024

EMA Recommends Granting a Marketing Authorisation for Biosimilar Denosumab

Ogkologos - April 16, 2024

Studies Assess Impact of Cancer Risk-Reduction Measures for People with BRCA...

Ogkologos - April 15, 2024

A Novel Model Helps Better Predict Risk of Cancer Development in...

Ogkologos - April 15, 2024

New on NCI’s Websites for April 2024

Ogkologos - April 12, 2024

FDA Grants Accelerated Approval to fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic...

Ogkologos - April 12, 2024

1...858687...440 Page 86 of 440

MOST POPULAR

FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma

August 27, 2024

Cancer waiting times: Latest updates and analysis

May 11, 2023

Significant Activity, Clinically Meaningful Functional and Symptomatic Improvements Observed in Patients...

June 20, 2024

Population Mortality from NSCLC in the US Fell Sharply Due to...

August 19, 2020

Efficacy and Safety of FOLFIRI With Durvalumab With or Without Tremelimumab...

Scientists Link a Single Type of Bacteria to Colorectal Cancer

FDA Approves Safety Labelling Changes Regarding DPD Deficiency for Fluorouracil Injection...

Adjuvant Alectinib Significantly Improves Disease-Free Survival in Patients with Resected ALK-positive...

Adding Gemcitabine to Cisplatin Once per Week Concurrently with IMRT Significantly...

EMA Recommends Granting a Marketing Authorisation for Biosimilar Denosumab

Studies Assess Impact of Cancer Risk-Reduction Measures for People with BRCA...

A Novel Model Helps Better Predict Risk of Cancer Development in...

New on NCI’s Websites for April 2024

FDA Grants Accelerated Approval to fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic...

MOST POPULAR

FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma

Cancer waiting times: Latest updates and analysis

Significant Activity, Clinically Meaningful Functional and Symptomatic Improvements Observed in Patients...

Population Mortality from NSCLC in the US Fell Sharply Due to...

HOT NEWS

pCR Associated with Improved Survival Outcomes in Patients with Soft Tissue...

FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction...

Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer

A Follow-Up Not Inferior to Radioiodine Ablation in Patients with Low-Risk...

POPULAR POSTS

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

POPULAR CATEGORY